Skip to main content
. 2002 Jul 5;2:12. doi: 10.1186/1471-2334-2-12

Table 2.

Spirometrya and sputum cell counts by Chlamydia pneumoniae DNA detection status among 92 patients with chronic obstructive pulmonary disease.

Number of Subjects Entire Study Group DNAb Present DNA Absent P-value (t-test)
Age in years (SD) 93 65.8 (10.7) 66.9 (11.9) 65.3 (10.3) 0.53
Smoking pack-years (SD) 93 43.1 (25.1) 48.9 (29.3) 41.8 (24.1) 0.22
FEV1c (SD), L 93 1.35 (0.61) 1.34 (0.64) 1.36 (0.61) 0.88
FEV1 % predicted (SD) 93 46.9 (16.8) 44.3 (15.1) 48.0 (17.5) 0.33
FEV1/VCd % (SD) 93 45.7 (15.4) 42.6 (15.8) 47.0 (15.2) 0.22
Total cell count, 106/g (SD) 73 10.9 (15.4) 9.9 (12.5) 11.4 (16.8) 0.70
Viability, % (SD) 73 61.5 (24.2) 60.4 (22.7) 62.0 (25.0) 0.79
Squamous Epithelial, % (SD) 73 3.8 (8.6) 3.7 (5.3) 3.9 (10.0) 0.92
Neutrophils, % (SD) 73 63.6 (25.3) 60.6 (27.2) 65.2 (24.5) 0.46
Macrophages, % (SD) 73 25.6 (19.2) 26.4 (21.2) 25.2 (18.3) 0.78
Eosinophils, median % (Inter-quartile range)e 73 1.2 (3.0) 1.2 (3.7) 1.0 (2.9) 0.71e

aAll spirometry after inhalation of 200 μg salbutamol. bC. pneumoniae DNA detected in peripheral blood mononuclear cells or induced sputum by nested polymerase chain reaction [14]. cFEV1: forced expiratory volume in 1 second. dVC: vital capacity. eComparison by Mann Whitney U test (SPSS).